EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results